General Motors | July 27, 2022
Livent and General Motors Co. announced today a significant multi-year sourcing agreement in which Livent will supply GM with battery-grade lithium hydroxide made primarily from lithium extracted at Livent's brine-based operations in South America. Lithium hydroxide is crucial to GM's plans to make higher performance, higher mileage EVs. The lithium hydroxide from Livent will be used in GM's Ultium battery cathodes, which will power electric vehicles such as the recently revealed Chevrolet Blazer EV, Chevrolet Silverado EV, GMC HUMMER EV and Cadillac LYRIQ.
Livent will provide battery-grade lithium hydroxide to GM over a six-year period beginning in 2025. Over the course of the agreement, Livent will increasingly supply battery-grade lithium hydroxide to GM from its manufacturing facilities in the U.S., with the goal of transitioning 100% of Livent's downstream lithium hydroxide processing for GM to North America. The agreement is expected to help secure supply for GM while assisting Livent in expanding its North American capabilities.
Both GM and Livent share a commitment to responsible operations and sustainable supply chains through industry and multi-stakeholder platforms. General Motors is a member of the Responsible Minerals Initiative (RMI), joined the Initiative for Responsible Mining Assurance (IRMA) in 2021 and plans to become carbon neutral in global products and operations by 2040. Livent is actively engaged in an IRMA third-party assessment, has a gold rating from EcoVadis for sustainability and has announced a goal of overall carbon neutrality by 2040.
"We are building a strong, sustainable, scalable and secure supply chain to help meet our fast-growing EV production needs, We will further localize the lithium supply chain in North America over the course of the agreement. In addition, it is aligned with our approach to responsible sourcing and supply chain management and demonstrates our commitment to strong supplier relationships. GM now has contractual commitments secured with strategic partners for all battery raw material to support our goal of 1 million units of EV capacity by the end of 2025"
-Jeff Morrison, vice president, Global Purchasing and Supply Chain, GM.
Paul Graves, president and chief executive officer of Livent commented, We are excited to begin this long-term relationship with GM, one of the most iconic brands in the automotive industry and a leading force in the transition to electrification. With a shared commitment to sustainability and responsible operations, we look forward to building a broad partnership that will support GM's electric vehicle strategy, its supply chain goals and the future requirements of its growing EV fleet for reliable, high-performance lithium products.
About General Motors-
General Motors (NYSE:GM) is a global company focused on advancing an all-electric future that is inclusive and accessible to all. At the heart of this strategy is the Ultium battery platform, which powers everything from mass-market to high-performance vehicles. General Motors, its subsidiaries and its joint venture entities sell vehicles under the Chevrolet, Buick, GMC, Cadillac, Baojun and Wuling brands. More information on the company and its subsidiaries, including OnStar, a global leader in vehicle safety and security services, can be found at https://www.gm.com.
Livent (NYSE: LTHM) is a fully integrated lithium company with a rich heritage of innovation and a long, proven history of producing performance lithium compounds. For nearly eight decades, Livent has partnered with its customers to safely and sustainably use lithium to power the world. Livent is one of only a small number of companies with the capability, reputation, and know-how to produce high-quality finished lithium compounds that are helping meet the growing demand for lithium. The company has one of the broadest product portfolios in the industry, powering demand for green energy, modern mobility, the mobile economy, and specialized innovations, including light alloys and lubricants.
Renault Group | June 29, 2022
A strategic partnership to develop and commercialize a one-of-a-kind technology solution for collecting and analysing manufacturing data on a large scale.
A new step toward industry digitalization is being taken by improving the operational performance of manufacturing equipment, resulting in higher productivity, fewer defects, and lower energy consumption.
This collaboration takes advantage of Renault Group's expertise and experience in digitalizing its manufacturing activities, as well as Atos' expertise as a key player in manufacturing digital transformation and consulting.
28 June 2022, Boulogne-Billancourt and Paris - ID@scale (Industrial Data @ Scale) is a new service for industrial data collection launched by Renault Group and Atos to assist manufacturing companies on their digital journey to Industry 4.0. Manufacturers will be able to collect and structure data from industrial equipment at scale using "ID@S" (Industrial Data @ Scale) to improve operational excellence and product quality.
Manufacturers generate a massive amount of data throughout the manufacturing process. Data is frequently underutilized due to its diversity and lack of standardization, as well as operator time constraints. Access to standardized data via simple analytical tools and dashboards facilitates and accelerates the deployment of many different types of use cases (production, maintenance, quality, and energies, for example), including net zero benefits.
Renault Group's IT, digital, and engineering teams created this solution to capture data from its manufacturing facilities as part of the company's digital transformation strategy. Data is collected and structured in a standardized manner for each type of manufacturing process, allowing a wide range of use cases in manufacturing, engineering, quality, CSR, logistics, and so on to be addressed. This solution is now being implemented on a large scale across twenty-two Renault Group plants. Over 7,500 pieces of equipment are linked, with standardized data models representing over 50 different manufacturing processes. Finally, the partnership is supported by the Group's Consulting and Services teams to market, deploy, and support the "as a service" solution worldwide, enabling rapid and agile deployment of new connectivity, data models, analytics, and insights for a customer within a few weeks.
OrthoPediatrics | July 16, 2022
OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced an exclusive distribution agreement with 3D-Side S.A., a Belgium based software developer and manufacturer of patient specific 3D printed cutting guides. This commercial agreement grants OrthoPediatrics exclusive distribution rights of the 3D-CUT-OSTEO osteotomy guide in the United States’ leading pediatric hospitals in addition to certain international markets in the future.
3D-CUT patient specific guides, designed from CT or MRI images, assist surgeons performing corrective and bone tumor resection osteotomies. The single use guide technology enables accurate deformity or tumor corrective procedures.
“The 3D-Side technology complements the OrthoPediatrics’ pediatric limb deformity implant and biologic offering, and increases exposure in the pediatric oncology market, where many of the most challenging orthopedic cases involving tumor resection require a full complement of solutions including implants, biologics, and patient specific devices. We are excited to enter this relationship with 3D-Side to provide our pediatric orthopedic customers access to the 3D-CUT products.”
-David Bailey President and CEO, OrthoPediatrics
3D-Side Co-CEO, Laurent Paul stated, Our partnership with OrthoPediatrics is based on a shared mission and commitment to limit the risks involved in surgery on medically challenged young patients. Because each patient is unique, we imagine dedicated solutions to fit their surgical needs. Thanks to the OrthoPediatrics partnership, we are thrilled to expand these well-established products in Europe to the USA and bring our expertise to pediatric orthopedic surgeons in the United States, said Laurent Paul, 3D-Side's Co-CEO.
About OrthoPediatrics Corp-
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 37 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 45 countries outside the United States.
About 3D-Side, S.A-
3D-Side is a Belgian company having developed first class products in cranioplasty, bone tumor surgery and deformity correction for more than 10 years. Its mission is to offer patient specific medical devices to allow planning of complex surgeries with incomparable quality. Based on this internal know-how, 3D-Side has developed a very specific vision on integrated surgical software and technologies. Through this vision, an innovative platform named Customize developed, connecting surgeons, patients, and medical device companies to optimize and streamline communication, creation and production of patient-specific medical devices. Personalization is in our DNA. We believe a tailor-made solution for each unique patient is key to, together with the surgeons, make surgeries a moment of confidence and persevere against risks. Ensuring that life wins in the end is at the heart of what we do. We are believers of 'together we are stronger’.